Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Levine

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Thrombosis Research|May 4, 2010
Thromboprophylaxis during chemotherapy: NOMark N Levine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Trastuzumab cardiac side effects: only time will tellMark N Levine
Cancer Treatment Reviews|September 18, 2002
Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancerMark N Levine
Cancer Treatment Reviews|July 31, 2003
Can we optimise treatment of thrombosis?Mark N Levine
Breast (Edinburgh, Scotland)|August 28, 2007
Adjuvant therapy and thrombosis: how to avoid the problem?Mark N Levine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
New antithrombotic drugs: potential for use in oncologyMark N Levine
Lancet (London, England)|November 6, 2023
Effective and safe regional node irradiation in early breast cancerMark N Levine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Conventional and complementary therapies: a tale of two research standards?Mark N Levine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Prevention of thrombosis in ambulatory patients with cancerPunam Rana, Mark N Levine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Method to our madness or madness in our methods? Pitfalls in trial methodologyMark N Levine, Rosalyn Juergens
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Thrombosis Research|May 4, 2010
Thromboprophylaxis during chemotherapy: NOMark N Levine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Trastuzumab cardiac side effects: only time will tellMark N Levine
Cancer Treatment Reviews|September 18, 2002
Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancerMark N Levine
Cancer Treatment Reviews|July 31, 2003
Can we optimise treatment of thrombosis?Mark N Levine
Breast (Edinburgh, Scotland)|August 28, 2007
Adjuvant therapy and thrombosis: how to avoid the problem?Mark N Levine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
New antithrombotic drugs: potential for use in oncologyMark N Levine
Lancet (London, England)|November 6, 2023
Effective and safe regional node irradiation in early breast cancerMark N Levine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Conventional and complementary therapies: a tale of two research standards?Mark N Levine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Prevention of thrombosis in ambulatory patients with cancerPunam Rana, Mark N Levine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Method to our madness or madness in our methods? Pitfalls in trial methodologyMark N Levine, Rosalyn Juergens
Pageof 12